berahyaluronidase alfa-pmph
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for berahyaluronidase alfa-pmph, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: FDA Approved: KEYTRUDA QLEX — Supplemental Application (Merck Sharp & Dohme LLC)